Skip to main content

Address And Details

PO Box 9130 , Boston, MA 02117
Fund Manager Team Managed
Manager Tenure

Strategy And Objective

The International Equity Portfolio (the Portfolio ) seeks long-term capital appreciation through investments in equity securities of companies based outside the United States. The Portfolio invests primarily in companies based in developed markets outside the United States as well as in companies in emerging and frontier markets. Harding Loevner LP ( Harding Loevner ), the Portfolio s investment adviser, undertakes fundamental research in an effort to identify companies that are well managed, financially sound, fast growing, and strongly competitive, and whose shares are reasonably priced relative to estimates of their value. To reduce its volatility, the Portfolio is diversified across dimensions of geography, industry, currency, and market capitalization. The Portfolio normally holds investments across at least 15 countries. Factors bearing on whether a company is considered to be based outside the United States may include: (1) it is legally domiciled outside the United States; (2) it conducts at least 50% of its business, as measured by the location of its sales, earnings, assets, or production, outside the United States; or (3) it has the principal exchange listing for its securities outside the United States. The Portfolio will normally invest broadly in equity securities of companies domiciled in the following countries and regions: (1) Europe; (2) the Pacific Rim; (3) Canada and Mexico; and (4) countries with emerging or frontier markets. At least 65% of the Portfolio s total assets will be denominated in at least three currencies other than the U.S. dollar. For purposes of compliance with this restriction, American Depositary Receipts, Global Depositary Receipts, and European Depositary Receipts (collectively, Depositary Receipts ), will be considered to be denominated in the currency of the country where the securities underlying the Depositary Receipts are principally traded. The Portfolio invests, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in common stocks, preferred stocks, rights, and warrants issued by companies that are based outside the United States, securities convertible into such securities (including Depositary Receipts), and investment companies that invest in the types of securities in which the Portfolio would normally invest. The Portfolio also may invest in securities of U.S. companies that derive, or are expected to derive, a significant portion of their revenues from their foreign operations, although under normal circumstances not more than 15% of the Portfolio s total assets will be invested in securities of U.S. companies. Because some emerging market countries do not permit foreigners to participate directly in their securities markets or otherwise present difficulties for efficient foreign investment, the Portfolio may use equity derivative securities, and, in particular, participation notes, to gain exposure to those countries.

Net Asset Value

as of 7:39 PM ET 11/29/2021

Performance

  • 1 Week
  • -2.59%
  • 1 Month
  • -3.03%
  • 3 Months
  • -3.91%
  • 1 Yr Return
  • +9.49%
  • 5 Yr Return
  • +68.23%

Equity Sector Breakdown

IndustrialCyclical 22.87%
Technology 17.09%
Finance 11.41%
RetailTrade 10.98%
NonDurables 5.33%
Energy 2.87%
ConsumerDurables 1.53%
Health 1.35%
Utilities 1.14%
Services 0.91%

Asset Allocation

Asset Type % Of Allocation
Stocks 96.20%
ForeignStocks 90.23%
Preferred 2.17%
Cash 0.00%
Bonds 0.00%
Convertible 0.00%
Other 0.00%
ForeignBonds 0.00%
ForeignHedged 0.00%
Total Net Assets 18.25 B

Risk Measures

Criteria 3 Years 5 Years 10 Years
Alpha -1.16 -2.36 -4.07
Beta 0.78 0.80 0.87
R Squared 0.78 0.70 0.69
Std Deviation 16.41 14.64 13.73
Sharpe Ratio 0.97 0.84 n/a

Purchase Information

as of 6:29 PM ET 11/26/2021
Minimum Initial $100000
Minimum Additional $0
Minimum Initial IRA $0

Performance

Timeframe Average Annual Current Performance Monthly As Of 10/31/2021 Average Annual Current Performance Quarterly As Of 09/30/2021 Avg Annual Current Performance Monthly As Of 10/31/2021 Avg Annual Current Performance Quarterly As Of 09/30/2021
1 Year
  • +30.16%
  • +20.50%
+30.16% +20.50%
3 Year
  • +15.42%
  • +9.93%
+15.42% +9.93%
10 Year
  • +9.35%
  • +9.98%
+9.35% +9.98%
Life Of Fund
  • +6.96%
  • +6.83%
+6.96% +6.83%

Top 10 Holdings

Symbol Company Name % Of Assets
ATCOA:SS ATLAS COPCO AB CL A 3.79%
TSM TAIWAN SEMICONDUCTOR MANUFACT 3.53%
OREP.PA L'OREAL SA 3.47%
ADYEN ADYEN NV 3.14%
0700.HK TENCENT HOLDINGS LTD 3.09%
BHP BHP GROUP LTD 3.06%
1299.HK AIA GROUP LTD 2.88%
ROG.S ROCHE HOLDING AG GENUSSS 2.82%
IFXGn.DE INFINEON TECHNOLOGIES AG 2.80%
SCHN.PA SCHNEIDER ELECTRIC SA 2.60%

LATEST NEWS

Recent Articles from TheStreet

Facebook Meta Logo Lead

Facebook Owner Meta told by U.K. Antitrust Regulator to Sell Giphy

Facebook parent Meta has been order by the U.K.’s competition watchdog to sell GIF-sharing platform Giphy, which it bought in 2020 for a reported $400 million.

Immunogen Tanks After Ovarian Cancer Drug Study Fails to Meet Endpoint

ImmunoGen Stock Soars On Positive Data From Ovarian Cancer Drug Trial

ImmunoGen said the data would be submitted to the U.S. Food & Drug Administration as party of the agency's' Biologics License Application process in the first quarter of next year.

Semiconductor Lead

Lam Research and KLA: 2 Must-Own Chip-Equipment Stocks

Amid the chip shortage, two key equipment stocks fly under the radar: Lam Research and KLA.

Merck Lead

Merck Covid-19 Pill to Be Reviewed by FDA Advisory Panel

Merck’s Covid-19 oral antiviral pill will be reviewed by an outside panel of advisors to the FDA on Tuesday, paving the way for potential authorization by year-end.

Moderna vaccine Lead

Moderna Stock Slumps, Regeneron Slides On Omicron Variant Efficacy Warnings

Moderna said its Covid vaccine would likely experience a 'material drop' in efficacy against Omicron, while Regeneron warned its antibody cocktail may also have reduced activity against the new variant.

Wall Street Lead

Moderna Warns on Omicron, Powell, Yellen Face Senate - 5 Things You Must Know

Stocks slump as Omicron concerns resurface; Moderna CEO cautions on vaccine efficacy against new variant; Powell and Yellen to testify before the Senate Banking Committee on CARES Act; FTC orders supply chain probe and cloud adoption software group HashiCorp seeks $13 billion valuation in upcoming Nasdaq IPO.

Wall Street Lead

Cramer's Mad Money Recap 11/29: Omicron, Amazon, Netflix

Jim Cramer reminds investors that the Omicron Covid variant doesn't pose systemic risks to the markets.

Lululemon Clothes Retail Lead

Lululemon Files Patent Lawsuit Against Peloton

Lululemon seeks injunction in leggings and sports bra design dispute with Peloton.

Jack Dorsey Lead

Jack Dorsey's Net Worth After Twitter Farewell

Twitter's departing CEO has maintained a detached view of his wealth and has donated a lot of it.

25 Freedom of the seas Royal Caribbean

Travel Companies Launch Cyber Week Vacation Sales Amid Omicron Woes

Airlines, cruise lines and other travel companies are throwing down Cyber Week deals in the face of new Omicron worries and travel restrictions.